Cti biopharma corp. (CTIC)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10Sep'09Jun'09
Revenues:
License and contract revenues

2,705

3,345

17,453

15,887

16,084

26,290

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

-

-

-

3,530

4,127

4,258

4,089

3,890

3,472

4,882

6,158

6,454

6,917

4,957

3,298

2,456

2,314

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

License and contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

18,154

53,278

55,335

52,035

45,973

12,644

17,699

54,993

54,940

53,160

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

21,684

57,405

59,593

56,124

49,863

16,116

22,581

61,151

61,394

60,077

75,172

36,000

34,963

34,678

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

Operating costs and expenses:
Cost of product sold

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sold

-

-

-

-

-

-

-

-

-

-

-

-

1,320

1,377

1,249

1,917

1,940

1,940

1,500

921

940

895

632

393

227

137

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

22,199

24,107

27,054

29,186

31,954

36,467

35,637

33,508

33,298

32,866

35,470

45,585

53,368

64,961

76,691

77,379

80,002

76,627

77,067

75,191

69,888

64,596

52,728

43,445

37,448

33,624

32,741

32,447

33,386

33,201

31,610

32,617

0

-

0

0

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

General and administrative

18,416

19,155

19,974

21,334

21,771

22,062

23,733

23,772

26,244

31,435

33,657

43,073

44,682

45,306

51,460

49,924

52,977

53,962

51,739

50,620

51,788

56,241

55,774

51,740

48,050

42,443

38,994

38,228

39,459

38,244

42,017

42,014

39,642

38,290

33,190

38,498

0

0

0

0

0

Settlement expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

0

0

Restructuring expenses

0

794

1,454

1,454

1,454

660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Other operating income

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Settlement expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other operating expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating costs and expenses

44,815

44,056

48,482

51,974

55,179

59,189

59,454

57,433

59,773

64,665

65,194

84,819

94,293

106,567

129,400

129,220

134,919

132,782

152,418

151,563

147,447

146,310

111,698

95,483

85,630

76,204

72,503

71,805

103,047

101,497

92,558

92,699

60,218

62,190

65,273

69,965

0

0

0

0

0

Loss from operations

-42,110

-40,711

-31,029

-36,087

-39,095

-32,899

-46,810

-43,807

-24,535

-39,519

-31,374

-48,271

-72,609

-49,162

-69,807

-73,096

-85,056

-116,666

-129,837

-90,412

-86,053

-86,233

-36,526

-59,483

-50,667

-41,526

-70,709

-70,373

-101,921

-101,497

-92,558

-92,699

-60,218

-62,190

-65,273

-69,666

0

0

0

0

0

Non-operating income (expense):
Interest income

911

1,172

1,422

1,582

1,599

1,219

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment and other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,395

1,651

1,672

1,545

-52

-37

0

0

0

0

-

Investment and other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest expense

875

1,002

1,119

1,187

1,215

1,209

1,286

1,435

1,626

1,872

2,068

2,245

2,434

2,614

1,750

2,404

2,324

2,104

2,923

2,107

1,977

1,947

1,749

1,593

1,442

1,026

685

412

99

56

149

267

486

870

1,157

1,772

0

0

0

0

0

Amortization of debt discount and issuance costs

521

521

522

521

521

525

444

352

259

163

150

150

151

214

216

218

311

390

532

677

731

729

712

689

668

513

0

0

0

-

-

-

-

546

602

0

0

0

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Foreign exchange loss

-120

-281

256

450

-1,194

-233

-856

-649

1,583

817

398

168

-725

-484

-249

-198

223

-703

-2,376

-4,813

-5,158

-4,435

-2,360

642

807

61

241

-90

-791

344

-598

-1,947

-933

-558

944

1,252

0

0

0

0

0

Other non-operating income

-

-

0

0

-

-

0

0

-

-

0

0

-

-479

-386

-227

-1,419

-900

-993

-1,196

1

-885

-1,153

-1,046

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative liabilities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Gain on exchange of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

-

Debt conversion expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Total non-operating expense, net

715

688

37

324

2,964

3,547

2,343

2,159

-396

-1,312

-1,748

-2,213

-3,270

-3,791

-2,601

-3,047

-3,831

-4,097

-6,824

-8,793

-7,865

-7,996

-5,819

-2,906

-2,463

-2,024

-1,525

-1,423

-1,853

-190

538

-802

-126

-429

-867

-3,280

0

0

0

0

0

Net loss before noncontrolling interest

-

-

-30,992

-35,763

-

-29,352

-44,467

-41,648

-24,931

-40,831

-33,122

-50,484

-75,879

-52,953

-72,408

-76,143

-88,887

-120,763

-136,661

-99,205

-93,918

-94,229

-42,345

-62,389

-53,130

-43,550

-72,234

-71,796

-103,774

-101,687

0

0

0

-

-

-

-

-

-

-

-

Net loss before noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Net loss before noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Noncontrolling interest

-

-

-6

-15

-

-32

-35

-51

-68

-161

-346

-499

-730

-944

-1,134

-1,460

-1,374

-1,341

-1,307

-1,046

-956

-862

-743

-640

-769

-807

-694

-611

-462

-313

-280

-288

-272

-259

-225

-211

0

0

0

0

0

Net Income (Loss) Attributable to Parent

-

-

-30,986

-35,748

-

-29,320

-44,432

-41,597

-24,863

-40,670

-32,776

-49,985

-75,149

-52,009

-71,274

-74,683

-87,513

-119,422

-135,354

-98,159

-92,962

-93,367

-41,602

-61,749

-52,361

-42,743

-71,540

-71,185

-103,312

-101,374

-91,740

-93,213

-60,072

-62,360

-65,915

-72,735

0

0

0

0

0

Preferred Stock Dividends and Other Adjustments

-

-

0

0

-

80

80

80

4,430

4,350

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

58,718

52,902

70,036

0

0

0

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Deemed dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net loss

-41,392

-40,020

-30,986

-35,748

-36,113

-29,400

-44,512

-41,677

-29,293

-45,020

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-121,078

-118,817

-142,771

0

0

0

0

0

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-0.71

0.12

-

-

-

-0.16

-

0.03

-

-

-

-0.20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-0.71

0.12

-

-

-

-0.16

-

0.03

-

-

-

-0.20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

31,725

-

-

-

27,960

27,793

-

-

-

173,936

-

145,138

-

-

-

110,996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

31,901

-

-

-

27,960

27,816

-

-

-

173,936

-

147,097

-

-

-

110,996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share (in dollars per share)

-0.20

-0.14

-0.17

-0.19

-0.19

0.02

-0.26

-0.20

-0.08

-

-0.28

-

-0.71

-

-1.04

-

-

-

-0.19

-0.19

-

-

-

-0.19

-0.20

-

-

-0.17

-0.18

0.21

-0.38

-1.38

-0.43

-2.24

-0.80

-0.14

-0.35

-0.13

-0.48

-0.09

-0.06

Shares used in calculation of basic and diluted net loss per common share (in shares)

62,461

57,976

57,974

57,973

57,973

58,075

57,964

57,941

50,312

-

42,878

-

28,045

-

28,002

-

-

-

176,004

175,458

-

-

-

144,453

142,138

-

-

107

106,697

96,255

52,921

42,532

40,792

-

36,999

165,373

-

-

-

-

-

Shares used in calculation of basic and diluted net loss per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

146,377

118,591

110,993

527,204

446,174